SMAD2 and neoplasm: Furthermore, both immunohistochemistry (IHC) and Western blotting identified elevated SULF1 expression and increased phosphorylation of SMAD2/3 (TGFB pathway activation) in tumor and peritumoral tissues from transgenic Sulf1-Tg mice compared with WT [27].